1. Tygstrup N, Jensen B. Intermittent intrahepatic cholestasis of unknown etiology in five young males from the Faroe Islands. Acta Med Scand. 1969;185:523-530.
2.
2. Bijleveld CM, Vonk RJ, Kuipers F, et al. Benign recurrent intrahepatic cholestasis: a long-term follow-up study of two patients [see comments]. Hepatology. 1989;9:532-537.
3.
3. Nakamuta M, Sakamoto S, MiyataY, et al. Benign recurrent intrahepatic cholestasis: a long-term follow-up. Hepatogastroenterology. 1994;41:287-289.
4.
4. Kakis G, Yousef IM. Pathogenesis of lithocholateand taurolithocholateinduced intrahepatic cholestasis in rats. Gastroenterology. 1978;75:595-607.
5.
5. Kuipers F, Havinga R, Vonk RJ. Cholestasis induced by sulphated glycolithocholic acid in the rat: protection by endogenous bile acids. Clin Sci. 1985;68:127-134.
6.
6. Bijleveld CM, Vonk RJ, Kuipers F, et al. Benign recurrent intrahepatic cholestasis: altered bile acid metabolism. Gastroenterology. 1989;97:427-432.
7.
7. Houwen RH, Baharloo S, Blankenship K, et al. Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasis. Nat Genet. 1994;8:380-386.
8.
8. Crosignani A, Podda M, Bertolini E, et al. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism [see comments]. Hepatology. 1991;13:1076-1083.
9.
9. Ghent CN. Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin. Am J Gastroenterol. 1987;82:117-118.
10.
10. Gregorio GV, Ball CS, Mowat AP, Mieli-Vergani G. Effect of rifampicin in the treatment of pruritus in hepatic cholestasis. Arch Dis Child. 1993;69:141-143.
11.
11. Bachs L, Pares A, Elena M, et al. Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology. 1992;102:2077-2080.
12.
12. Ghent CN, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology. 1988;94:488-493.
13.
13. Podesta A, Lopez P, Terg R, et al. Treatment of pruritus of primary biliary cirrhosis with rifampin. Dig Dis Sci. 1991;36:216-220.
14.
14. Cynamon HA, AndresJM, lafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology. 1990;98:1013-1016.
15.
15. Capelle P, Dhumeaux D, Mora M, et al. Effect of rifampicin on liver function in man. Gut. 1972;13:366-371.
17. GrossetJ, Leventis S. Adverse effects of rifampin. Rev Infect Dis. 1983; 5(Suppl 3):S440-S450.
18.
18. Worlledge S: Rifampicin-induced antibodies. In: Williams JD, Geddes AM, eds. Pharmacology of Antibiotics: Proceedings of the Ninth International Congress of Chemotherapy. New York: Plenum Press; 1976:273-278.
19.
19. Flynn CT, Rainford DJ, Hope E. Acute renal failure and rifampicin: danger of unsuspected intermittent dosage. Br MedJ. 1974;2:482-482.
20.
20. Rothwell DL, Richmond DE. Hepatorenal failure with self-initiated intermittent rifampicin therapy. Br Med j1974;2:481-482.
